TRPV4-ANTAGONISTEN

European patent · EP2721016 · In force

Register entry

Publication number
EP2721016
Application number
EP12814591
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 15, 2012
Published
Apr 23, 2014
Granted
Apr 6, 2016
Protection ends at the latest
Jun 14, 2032
Next annual fee due
Jun 30, 2027
IPC classes
C07D 263/52 (2006.01)
C07D 498/00 (2006.01)
C07D 419/14 (2006.01)
Priority
US 201161498110 P 17.06.2011
PCT application
PCT/US2012/042622 15.06.2012
PCT publication
WO2013/012500 24.01.2013
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. Dec 16, 2025

    Corrected

    Owner
    GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom → GlaxoSmithKline Intellectual Property (No. 2) Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

    Published in Swissreg on 16.12.2025

  3. Nov 7, 2025

    Holder’s address changed

    Owner
    GlaxoSmithKline Intellectual Property (No.2), Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → GlaxoSmithKline Intellectual Property Development, Limited, GSK Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, United Kingdom

    Published in Swissreg on 07.11.2025

  4. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  5. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  6. Dec 20, 2023

    Address changed

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 20.12.2023

  7. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  8. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

3 earlier entries
  1. Sep 23, 2021

    Transferred

    Owner
    Glaxosmithkline Intellectual Property (No. 2), Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom → GlaxoSmithKline Intellectual Property (No.2), Limited, 980 Great West Road, Brentford, Middlesex TW8 9GS, United Kingdom

    Published in Swissreg on 23.09.2021

  2. May 20, 2016

    Agent entered

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in Swissreg on 20.05.2016

  3. Apr 6, 2016

    Granted

    Published in Swissreg on 06.04.2016

Parties

Inventor

BROOKS, Carl

King of Prussia, PA 19406, US

CHEUNG, Mui

King of Prussia, PA 19406, US

EIDAM, Hilary, Schenck

King of Prussia, PA 19406, US

GOODMAN, Krista, B.

King of Prussia, PA 19406, US

HAMMOND, Marlys

Littleton, CO 80123, US

HILFIKER, Mark, A.

King of Prussia, PA 19406, US

HOANG, Tram, H.

King of Prussia, PA 19406, US

PATTERSON, Jaclyn, R.

King of Prussia, PA 19406, US

STOY, Patrick

King of Prussia, PA 19406, US

YE, Guosen

King of Prussia, PA 19406, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.